Endovascular treatment in ischemic strokes with large infarct core: an updated systematic review and meta-analysis of randomized controlled trials
- PMID: 39347866
- DOI: 10.1007/s10072-024-07781-5
Endovascular treatment in ischemic strokes with large infarct core: an updated systematic review and meta-analysis of randomized controlled trials
Abstract
Background: Endovascular treatment (EVT) is recommended for acute ischemic stroke due to large-vessel occlusion (LVO) and an ASPECTs ≥ 6. Recent randomized controlled trials (RCTs) have become available on effect of EVT in patients with LVO-related large core infarct stroke (ASPECTS 0-5). We conducted a systematic review and meta-analysis of trials on patients with large core infarct treated with thrombectomy compared to best medical therapy (BMT).
Methods: The study followed PRISMA guidelines. Primary endpoint was functional independence at 90 days (modified Rankin Scale mRS < 3). Secondary endpoints were 3-month moderate disability (mRS < 4), excellent outcome (mRS < 2) and change in mRS (shift analysis). Safety outcomes were: symptomatic intracranial hemorrhage (sICH) and 3-month mortality.
Results: Seven RCTs were included with a total of 1964 patients. Functional independence was significantly more frequent in EVT vs BMT group (19.4% vs 8%; OR = 2.72, 95%CI = 2.06-3.61, pheterogeneity = 0.08; I2: 47%). Moderate outcome was also more prevalent in EVT group (OR = 2.00; 95%CI = 1.61 - 2.48, pheterogeneity = 0.17; I2: 46%) as well as excellent outcome (OR: 1.54, 95%CI = 1.07 - 2.22, pheterogeneity = 0.13; I2: 40%). Shift analysis was also significant with OR 1.59 (CI = 1.33-1.82 and p < 0.001). Finally sICH, that occurred in 68 patients, was more frequent in EVT (OR = 1.63, 95%CI = 0.99 - 2.69, pheterogeneity = 0.68; I2: 0%) while 3 m mortality was reduced in EVT (31% vs 37,1%, OR 0.76 CI = 0.62-0.92).
Conclusions: This updated pooled data show that, in LVO-stroke patients with a large core infarct, EVT plus BMT (as compared to BMT alone) increases significantly the chances of achieving a good functional outcome at 90 days and reduces the 3- month mortality despite a marginal increase in acute sICH.
Keywords: Large ischemic stroke; Mechanical thrombectomy; Meta-analysis; Randomized controlled trial.
© 2024. Fondazione Società Italiana di Neurologia.
Conflict of interest statement
Declarations. Ethical approval: Since we conducted a pooled analysis of aggregate data (not individual) from published randomized controlled trials, patient informed consent for this study was not collected. Meta-analysis followed PRISMA guideline and study protocol was deposited with OSF ( https://doi.org/10.17605/OSF.IO/CPW97 ). Competing interests: LP received consultancy fees from Amicus and PIAM.
Similar articles
-
Endovascular Thrombectomy for Large Core Volume Acute Ischemic Stroke. Updated Systematic Review and Meta-Analysis: Thrombectomy for large core acute ischemic strokes.J Stroke Cerebrovasc Dis. 2025 Jan;34(1):108135. doi: 10.1016/j.jstrokecerebrovasdis.2024.108135. Epub 2024 Nov 12. J Stroke Cerebrovasc Dis. 2025. PMID: 39537044
-
Endovascular thrombectomy in acute stroke with a large ischemic core: A systematic review and meta-analysis of randomized controlled trials.PLoS Med. 2025 Apr 17;22(4):e1004484. doi: 10.1371/journal.pmed.1004484. eCollection 2025 Apr. PLoS Med. 2025. PMID: 40245084 Free PMC article.
-
Mechanical Thrombectomy in Ischemic Stroke with a Large Infarct Core: A Meta-Analysis of Randomized Controlled Trials.J Clin Med. 2024 Jul 23;13(15):4280. doi: 10.3390/jcm13154280. J Clin Med. 2024. PMID: 39124547 Free PMC article. Review.
-
Endovascular Thrombectomy for Large Ischemic Core Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Neurology. 2025 May 13;104(9):e213443. doi: 10.1212/WNL.0000000000213443. Epub 2025 Apr 17. Neurology. 2025. PMID: 40245349
-
Endovascular thrombectomy for ischemic stroke with large infarct, short- and long-term outcomes: a meta-analysis of 6 randomised control trials.Neurol Sci. 2024 Dec;45(12):5627-5637. doi: 10.1007/s10072-024-07662-x. Epub 2024 Jul 3. Neurol Sci. 2024. PMID: 38958794
Cited by
-
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints.Eur J Neurol. 2025 Mar;32(3):e70112. doi: 10.1111/ene.70112. Eur J Neurol. 2025. PMID: 40084618 Free PMC article.
-
Advances in Ischemic Stroke Treatment: Current and Future Therapies.Neurol Ther. 2025 Aug 13. doi: 10.1007/s40120-025-00810-1. Online ahead of print. Neurol Ther. 2025. PMID: 40797003 Review.
References
-
- Berge E, Whiteley W, Audebert H et al (2021) European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 6(1):I–LXII. https://doi.org/10.1177/2396987321989865 - DOI - PubMed - PMC
-
- Turc G, Bhogal P, Fischer U et al (2023) European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic Stroke Endorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J 4:6–12. https://doi.org/10.1177/2396987319832140 - DOI
-
- Goyal M, Menon BK, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-X - DOI - PubMed
-
- Yoo A, Zaidat OO, Al Kasab S et al (2023) Intraarterial treatment versus no intraarterial treatment within 24 hours in patients with ischaemic stroke and large infarct on noncontrast CT (TESLA): a multicentre, open-label, blinded-endpoint, randomised, controlled, Phase 3 Trial. Lancet 2023:95–98 (pre-print)
-
- Sarraj A, Hassan AE, Abraham MG et al (2023) Trial of Endovascular Thrombectomy for Large Ischemic Strokes. N Engl J Med 388:1259–1271. https://doi.org/10.1056/NEJMoa2214403 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical